$IEHC

Rosenfeld Michael E sold $139K of IEHC

Rosenfeld Michael E sold 4,240 shares of IEH Corp (IEHC) at an average of $32.85 ($32.50–$33.00, $0.14M total) across 2 trades over 2026-08-13 to 2026-08-14.

Original reporting
SEC EDGAR · Rosenfeld Michael E
Published Aug 20, 2026, 8:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IEHC
Bearish
medium confidence
Mentioned
$IEHC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IEHCBearishLow
01

Why it matters

The director's sale reduces his ownership, which may be interpreted as a lack of confidence, but the amount is small.

02

Market read

Primary relevance is to IEHC shareholders; limited broader market effect.

03

What to watch

No other material news accompanies the filing; market may already price in the insider transaction.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filings disclose insider transactions; this is the first public report of this sale.

Company-level read

Ticker impact

$IEHCBearishMedium confidence
Context

Director Michael E. Rosenfeld sold 4,240 shares for $139,300 on Aug 13-14, reducing his stake to 760 shares.

Expected impact

Modest downward pressure over the next few days.

Evidence & confidence

The sale size is modest relative to market cap, but insider disposition can influence sentiment.

Market effects

Minimal impact on the broader sector; only relevant to IEHC investors.

None

None

Counterpoint

The sale could be routine liquidity need, not a negative signal.

Key entities

  • IEH Corp

    Issuer of the securities sold.

  • Michael E. Rosenfeld

    Director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).